Editas Medicine, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 8.02 M | $27.83 M | 17.58% | 9.50% |
| VANGUARD GROUP INC | 11/07/2025 | 6.97 M | $24.17 M | -2.71% | 8.25% |
| NUVEEN, LLC | 11/12/2025 | 2.09 M | $7.26 M | 120.21% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.04 M | $7.08 M | 3.86% | 2.42% |
| STATE STREET CORP | 11/14/2025 | 1.93 M | $6.68 M | 4.23% | 2.28% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.58 M | $5.50 M | 63.33% | 1.88% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.28 M | $4.43 M | 43.79% | 1.51% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.21 M | $4.18 M | 28.11% | 1.43% |
| MORGAN STANLEY | 11/14/2025 | 1.09 M | $3.78 M | -23.42% | 1.29% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.02 M | $3.55 M | -5.14% | 1.21% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 931.91 K | $3.23 M | -33.66% | 1.10% |
| JPMORGAN CHASE & CO | 11/26/2025 | 820.67 K | $2.85 M | -22.99% | 0.97% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/17/2025 | 800.02 K | $2.78 M | 761.70% | 0.95% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 799.21 K | $2.77 M | -15.33% | 0.95% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 779.96 K | $2.71 M | 11.18% | 0.92% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 687.76 K | $2.39 M | -10.40% | 0.81% |
| NORTHERN TRUST CORP | 11/14/2025 | 669.69 K | $2.32 M | 1.41% | 0.79% |
| STIFEL FINANCIAL CORP | 11/12/2025 | 580.29 K | $2.01 M | 4.51% | 0.69% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 565.64 K | $1.96 M | -0.35% | 0.67% |
| JANE STREET GROUP, LLC | 11/14/2025 | 516.60 K | $1.79 M | 97.57% | 0.61% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 458.28 K | $1.59 M | -30.43% | 0.54% |
| UBS GROUP AG | 11/13/2025 | 422.39 K | $1.47 M | -32.99% | 0.50% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 393.83 K | $1.37 M | 100.00% | 0.47% |
| CITADEL ADVISORS LLC | 11/14/2025 | 362.19 K | $1.26 M | -43.29% | 0.43% |
| ROYAL BANK OF CANADA | 11/14/2025 | 358.22 K | $1.24 M | 16.10% | 0.42% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 356.66 K | $1.24 M | -9.05% | 0.42% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 335.79 K | $1.17 M | -82.11% | 0.40% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 308.33 K | $1.07 M | 100.00% | 0.37% |
| DIADEMA PARTNERS LP | 11/14/2025 | 300.00 K | $1.04 M | 100.00% | 0.36% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 295.26 K | $1.02 M | 100.00% | 0.35% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 286.48 K | $994.09 K | 2,088.72% | 0.34% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 264.69 K | $918.46 K | 8.73% | 0.31% |
| XTX TOPCO LTD | 11/14/2025 | 260.11 K | $902.59 K | 95.67% | 0.31% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2025 | 241.69 K | $838.67 K | -1.79% | 0.29% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 231.86 K | $804.00 K | 69.92% | 0.27% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 188.14 K | $652.86 K | 100.00% | 0.22% |
| BARCLAYS PLC | 11/12/2025 | 187.05 K | $649.06 K | -6.25% | 0.22% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 11/12/2025 | 178.39 K | $619.00 K | 1.01% | 0.21% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 167.53 K | $581.33 K | -8.80% | 0.20% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 163.89 K | $568.69 K | -10.01% | 0.19% |
| IEQ CAPITAL, LLC | 11/14/2025 | 150.67 K | $522.81 K | -2.50% | 0.18% |
| GREEN ALPHA ADVISORS, LLC | 10/15/2025 | 146.41 K | $508.05 K | -14.27% | 0.17% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 132.60 K | $460.12 K | 100.00% | 0.16% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 128.31 K | $445.24 K | -5.66% | 0.15% |
| RHUMBLINE ADVISERS | 11/06/2025 | 122.53 K | $425.15 K | -3.37% | 0.15% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 117.68 K | $408.34 K | -13.45% | 0.14% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 116.18 K | $403.14 K | 5.51% | 0.14% |
| FMR LLC | 11/13/2025 | 99.66 K | $345.81 K | 1.75% | 0.12% |
| HSBC HOLDINGS PLC | 11/13/2025 | 95.90 K | $325.57 K | 80.84% | 0.11% |
| CITADEL ADVISORS LLC | 11/14/2025 | 94.70 K | $328.61 K | -16.19% | 0.11% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Editas Medicine, Inc. institutional Ownership - FAQ's
During the previous two years, 285 institutional investors and hedge funds held shares of Editas Medicine, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 8.02 M
VANGUARD GROUP INC: 6.97 M
Nuveen, LLC: 2.09 M
GEODE CAPITAL MANAGEMENT, LLC: 2.04 M
STATE STREET CORP: 1.93 M
TWO SIGMA INVESTMENTS, LP: 1.58 M
51.06% of Editas Medicine, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 63.37 M shares in the last 24 months. This purchase volume represents approximately $153.98 M in transactions.